SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the March 2023 quarter moved down -48.35% to Rs. 212.17 millions as compared to Rs. 410.80 millions during the year ago period.The Net Loss for the quarter ended March 2023 is Rs. -17.99 millions as compared to Net Loss of Rs. -11.66 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 further decreased to -16.61% as compared to -8.18% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 212.17 410.80 -48.35 1118.99 2555.49 -56.21 1118.99 2555.49 -56.21
Other Income 21.53 17.14 25.61 71.65 77.20 -7.19 71.65 77.20 -7.19
PBIDT -16.61 -8.18 103.06 -82.25 634.93 -112.95 -82.25 634.93 -112.95
Interest 1.00 2.78 -64.03 4.31 7.31 -41.04 4.31 7.31 -41.04
PBDT -17.61 -10.96 60.68 -86.56 627.62 -113.79 -86.56 627.62 -113.79
Depreciation 5.35 5.71 -6.30 23.01 14.32 60.68 23.01 14.32 60.68
PBT -22.96 -16.67 37.73 -109.57 613.30 -117.87 -109.57 613.30 -117.87
TAX -4.97 -5.01 -0.80 -25.35 160.21 -115.82 -25.35 160.21 -115.82
Deferred Tax -5.38 3.23 -266.56 -25.76 4.51 -671.18 -25.76 4.51 -671.18
PAT -17.99 -11.66 54.29 -84.22 453.09 -118.59 -84.22 453.09 -118.59
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) -7.83 -1.99 293.16 -7.35 24.85 -129.58 -7.35 24.85 -129.58

Nureca Ltd. Share Price

263.80 1.30 (0.50%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 534.85
Poly Medicure 1468.25
Laxmi Denta 195.10
Nureca Ltd. 263.80
Hemant Surgical Inds 297.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×